Coronavirus Disease 2019 (COVID-19): Information for NIH Applicants and Recipients of NIH Funding

The NIH is deeply concerned for the health and safety of people involved in NIH research, and about the effects on the biomedical enterprise in the areas affected by the HHS declared public health emergency for COVID-19. Due to the potential exceptional impact, we want to assure our recipient community that NIH will be doing our part to help you continue your research.

This is a rapidly evolving situation and we will provide updated guidance and information as it becomes available.

Posted 3/17/2020     Duration 8:39

An overview of considerations for late applications,  administrative flexibilities, 
clinical trials and studies that involve human subjects,  unanticipated costs, animal research related to COVID-19.

Guidance

Proposal Submission & Award Management

• NIH Late Application Policy Due to Public Health Emergency for United States for 2019 Novel Coronavirus (COVID-19) - NOT-OD-20-082
• General Frequently Asked Questions (FAQs) - Proposal Submission and Award Management Related to COVID-19 - NOT-OD-20-083
• Flexibilities Available to Applicants and Recipients of Federal Financial Assistance Affected by COVID-19 - NOT-OD-20-086

Human Subjects & Clinical Trials

• Guidance for NIH-funded Clinical Trials and Human Subjects Studies Affected by COVID-19 - NOT-OD-20-087
• FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic

Animal Welfare

• OLAW Webinar: Pandemic Contingency Planning and Its Impact on Animal Care - March 19, 2020 1:00 PM
• Flexibilities for Assured Institutions for Activities of Institutional Animal Care and Use Committees (IACUCs) Due to COVID-19 - NOT-OD-20-088

Peer Review

• Based on NIH Guidance on Travel and Meetings, in-person NIH peer review meetings are being held in alternate formats. Scientific review officers will be in contact with peer reviewers about these changes.

Funding Opportunities Specific to COVID-19

• ​​Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCoV)
• Notice of Special Interest (NOSI): Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)

FAQs

• NIH FAQs: COVID-19 Flexibilities for Applicants and Recipients

Resources

• NIH Website: Coronavirus Disease 2019 (COVID-19)
• CDC Website: Coronavirus Disease 2019 (COVID-19) including its guidance for Institutes of Higher Education and for mental health and coping
• WHO Website: Coronavirus disease (COVID-19) outbreak
• General Information on NIH Extramural Response to Natural Disasters and Other Emergencies